Lycopene in the Prevention of Radiation-Induced Esophagitis

被引:8
|
作者
Coskun, Hatice [1 ]
Andic, Fundagul [1 ]
Daglioglu, Yusuf Kenan [2 ]
Doran, Figen [3 ]
Sahin, Kazim [4 ]
Tunali, Candas [1 ]
Kucuk, Omer [5 ]
机构
[1] Cukurova Univ, Dept Radiat Oncol, Fac Med, Adana, Turkey
[2] Cukurova Univ, Expt Med Res Ctr, Adana, Turkey
[3] Cukurova Univ, Dept Pathol, Fac Med, Adana, Turkey
[4] Firat Univ, Dept Anim Nutr, Fac Vet Sci, Elazig, Turkey
[5] Emory Univ, Dept Med, Winship Canc Inst, Atlanta, GA 30322 USA
来源
关键词
CELL LUNG-CANCER; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; IRRADIATION-INDUCED ESOPHAGITIS; SUPEROXIDE-DISMUTASE TRANSGENE; HIGH-DOSE RADIATION; GROUP RTOG TRIALS; CONCURRENT CHEMOTHERAPY; GENE-THERAPY; RANDOMIZED-TRIAL; SINGLET OXYGEN;
D O I
10.1080/01635581.2017.1265133
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We aimed to research whether lycopene (L) could prevent radiation-induced acute esophageal toxicity in Wistar albino rats. 60 rats were placed in five groups as follows: control, L, radiotherapy (RT), L before RT (L + RT), and L before and after RT (L + RT + L). 6mg/kg bw/day L was administered 7days in the L group, 7days before RT in the L + RT group, and 7days before and after in the L + RT + L group. 35Gy thoracic RT was performed. Serum L levels were measured, and the esophagi were evaluated histopathologically for intraepithelial degenerative changes-necrosis, vacuole formation, inflammation, regeneration-mitosis, and subepithelial bulla formation. L levels were significantly higher in the L receiving groups. All histopathologic results were significantly worse in the RT group than in the none-RT groups. The L + RT and the L + RT + L groups had better results than the RT group. Grade 2-3 degenerative changes-necrosis and vacuole formation were significantly lesser in the L + RT and the L + RT + L groups than those in the RT group. There was a trend toward decreased subepithelial bulla formation and inflammation in the L + RT and the L + RT + L groups compared to the RT group. Regeneration-mitosis was insignificantly lesser in the L + RT and significantly fewer in the L + RT + L groups than that in the RT group.
引用
收藏
页码:319 / 329
页数:11
相关论文
共 50 条
  • [31] RADIATION-INDUCED CANCER - RISK ASSESSMENT AND PREVENTION
    SHORE, RE
    CANCER DETECTION AND PREVENTION, 1984, 7 (03): : 181 - 190
  • [32] The effect of verapamil in the prevention of radiation-induced cataract
    Cengiz, M
    Gürkaynak, M
    Atahan, IL
    Kilic, K
    Totan, Y
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (03): : 623 - 626
  • [33] Use of probiotics for prevention of radiation-induced diarrhea
    P Delia
    G Sansotta
    V Donato
    P Frosina
    G Messina
    C De Renzis
    G Famularo
    World Journal of Gastroenterology, 2007, (06) : 912 - 915
  • [34] PREVENTION OF RADIATION-INDUCED STENOSIS OF THE NASOLACRIMAL DUCT
    DESMET, MD
    BUFFAM, FV
    FAIREY, RN
    VOSS, NJS
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 1990, 25 (03): : 145 - 147
  • [35] Radiation-induced Xerostomia: Pathophysiology, Prevention and Treatment
    Bhide, S. A.
    Miah, A. B.
    Harrington, K. J.
    Newbold, K. L.
    Nutting, C. M.
    CLINICAL ONCOLOGY, 2009, 21 (10) : 737 - 744
  • [36] Use of probiotics for prevention of radiation-induced diarrhea
    Blanarova, C.
    Galovicova, A.
    Petrasova, D.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2009, 110 (02): : 98 - 104
  • [37] Prevention and treatment of radiation-induced bowel injuries
    SchratterSehn, AU
    ONKOLOGIE, 1997, 20 (05): : 418 - 421
  • [38] Sucralfate in the prevention of radiation-induced oral mucositis
    Cengiz, M
    Özyar, E
    Öztürk, D
    Akyol, F
    Atahan, IL
    Hayran, M
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1999, 28 (01) : 40 - 43
  • [39] PREVENTION AND THERAPY OF RADIATION-INDUCED BOWEL DISCOMFORT
    HENRIKSSON, R
    FRANZEN, L
    LITTBRAND, B
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 : 7 - 11
  • [40] Prevention of radiation-induced oral mucositis with benzydamine
    Ehab Y. Hanna
    Current Oncology Reports, 2002, 4 (1) : 65 - 67